Expert panel discussion on on the use of palbociclib in endocrine-resistant breast cancer. Learn about the clinical trial and optimize treatment strategies.
Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar S M ,Dr. Vishwanath S
Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the latest treatment strategies for relapsed/refractory adult B-cell ALL.
Speakers : Dr. Pawan Kumar Singh ,Dr. Roshan Dixit ,Dr. Manisha Jain ,Dr. Avruti Baweja
Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the cost and hospitalization burden for R/R ALL patients.
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
Explore the long-term survival outcomes of iontuzumab-treated patients in the INO-VATE trial with experts Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja.
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on Iontuzumab’s impact on CR/CRi rates and MRD negativity in leukemia.
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Roshan Dikshit , Dr. Avriti Baveja
Learn about CAR T-cell therapy, bispecific antibodies, and personalized treatment strategies. Watch now for cutting-edge recommendations!
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
1.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
2.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
3.
Racial differences seen in epigenetic age acceleration in childhood cancer survivors
4.
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer
5.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
1.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
2.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
3.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
4.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation